The alarming increase in obesity worldwide is of concern mainly because of the associations of obesity with the metabolic syndrome, characterized by central obesity, insulin resistance, hyperglycemia, dyslipidemia and hypertension; all risk factors for cardiovascular diseases and type 2 diabetes mellitus. Therefore, the identification of new early biomarkers of susceptibility is relevant to intervene with lifestyle and nutritional changes before the disease is manifested. Blood cells are useful as potential source of transcript-based biomarkers in human samples because they are easily accessible and changes in gene expression in these cells may reflect processes occurring at internal organs. Thus, the objective of this study was to evaluate, in blood samples of normal weight and overweight children, whether the expression levels of selected genes involved in energy homeostasis, such as InsR, CPT1A, SLC27A2, FASN and PPARa, are related with the dyslipidemic state associated with obesity. Blood samples were obtained from 306 normal-weight and overweight children, aged 2-9 years, from 8 different European countries. Whole-blood mRNA levels were assessed by RT-qPCR. Overweight children displayed higher triglyceride levels than normal-weight children. However, overweight children with high expression levels of InsR or CPT1A, did not show the increase in triglyceride levels associated with fat accumulation, while no effect was found apparently in normal weight children. With respect to SLC27, FASN and PPARa, both normal weight and overweight children with high expression levels of these genes exhibited lower triglyceride levels. In conclusion, expression levels of InsR, CPT1A, SLC27, FASN or PPARa in blood cells may be used as biomarkers of the metabolic status in overweight children, particularly in terms of triglyceridemia, potentially providing an early warning of future disorders.
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